Innoviva (INVA) Raw Materials (2012 - 2026)
Innoviva (INVA) posted Raw Materials of $17.5 million for Q1 2026, up 6.93% on a QoQ basis from $16.3 million in Q4 2025, and up 64.44% year-over-year from $10.6 million in Q1 2025.
Innoviva (INVA) Raw Materials (2012 - 2026) Analysis & Trends
Innoviva's Raw Materials history runs 8 years deep, the most recent figure standing at $17.5 million for Q1 2026.
- Quarterly Raw Materials rose 64.44% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (up 64.44% YoY) and the FY2025 annual result came in at $16.3 million, up 46.95% from the prior year.
- Raw Materials was $17.5 million for Q1 2026 at Innoviva, up from $16.3 million in the prior quarter.
- Across five years, Raw Materials topped out at $17.5 million in Q1 2026 and bottomed at $5.8 million in Q3 2022.
- A 5-year average of $10.4 million and a median of $9.5 million in 2024 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2023 — Raw Materials surged 95.54% — and 2024, when it fell 1.28%.
- Innoviva's Raw Materials stood at $5.8 million in 2022, then jumped by 95.54% to $11.3 million in 2023, then declined by 1.28% to $11.1 million in 2024, then surged by 46.95% to $16.3 million in 2025, then increased by 6.93% to $17.5 million in 2026.
- Business Quant data shows INVA's Raw Materials at $17.5 million in Q1 2026, $16.3 million in Q4 2025, and $14.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.46 Mn |
| Dec 31, 2025 | 16.33 Mn |
| Sep 30, 2025 | 14.37 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 9.53 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | 9.53 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 8.86 Mn |
| Jun 30, 2023 | 8.86 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 5.76 Mn |
| Mar 31, 2014 | 4.00 Mn |
| Dec 31, 2013 | 5.14 Mn |
| Sep 30, 2013 | 4.08 Mn |
| Jun 30, 2013 | 3.53 Mn |
| Mar 31, 2013 | 8.05 Mn |